[ET Net News Agency, 5 September 2025] 3SBIO (01530) rose 17% to HK$35.3.
It hits an intra-day high of HK$35.36, hitting a historical high, breaking above the 20-D SMA of HK$30.872, and an intra-day low of HK$30.5. The total shares traded was 89.91 million, with a value of HK$2.98b. The active buy/sell ratio is 65:35, with net buying turnover of HK$874.19m. BARCLAYS CAPITAL ASIA accounts for greatest net responsive buying turnover of HK$55.87m, with volume weighted average price of HK$33.504. CHINA INV INFO accounts for greatest net responsive selling turnover of HK$276.28m, with volume weighted average price of HK$33.314.
Basic Information| Nominal | 35.300 | % Chg | +17.04% |
| High | 35.360 | Low | 30.500 |
| Shares Tr | 89.91m | Turnover | 2.98b |
| 10-D SMA | 30.336 | %H.V | 52.726 |
| 20-D SMA | 30.872 | VWAP | 33.185 |
| 50-D SMA | 29.288 | RSI14 | 64.657 |
Status: Breaking above the 20-D SMA, hitting a historical high, active buy/sell ratio is 65:35, with net buying turnover of HK$874.19m
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| 3SBIO (01530) | 35.30 | +17.04 |
| SINO BIOPHARM (01177) | 8.98 | +7.03 |
| EVEREST MED (01952) | 61.00 | +3.13 |
| KEYMED BIO-B (02162) | 77.40 | +12.99 |
| WUXI XDC (02268) | 65.80 | +4.20 |
| SKB BIO-B (06990) | 525.00 | +6.84 |
| ZAI LAB (09688) | 24.40 | +5.90 |
| AKESO (09926) | 156.00 | +5.98 |
| INNOCARE (09969) | 17.95 | +2.98 |
| REMEGEN (09995) | 93.80 | +3.70 |
(ed)
